QA: Paratek Pharmaceuticals Inc in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2012_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 65,837,000
1 IntangibleAssetsNetIncludingGoodwill 2,962,000
2 PropertyPlantAndEquipmentNet 314,000
3 remainder_Assets 38,000
4 LiabilitiesCurrent 3,339,000
5 LiabilitiesNoncurrent 60,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,185,000
9 ResearchAndDevelopmentExpense 11,273,000
10 remainder_Expenses 9,000
11 remainder_Revenues 19,694,000
12 remainder_NetIncome -107,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 69,151,000
1 Liabilities 3,399,000
2 Expenses 23,467,000
3 Revenues 19,694,000
4 StockholdersEquity 65,752,000
5 NetIncome -3,880,000
6 ComprehensiveNetIncome -3,880,000
7 BaseVar 57,909,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.84
9 EconomicCapitalRatio 4.28

Edgar->Model Mapping

Feature Distribution